BFEC
PRME icon

Benjamin F. Edwards & Company’s Prime Medicine PRME Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$130K Buy
25,326
+24,899
+5,831% +$151K ﹤0.01% 1037
2024
Q1 		$3K Buy
+427
New +$3.24K ﹤0.01% 1973

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Benjamin F. Edwards & Company's PRME Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Prime Medicine (PRME) stake by 5,831% in Q2 2024, buying an estimated $151K and bringing the position to 25,326 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Benjamin F. Edwards & Company first reported a position in PRME in Q1 2024 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold PRME as of Q2 2024.

  • Benjamin F. Edwards & Company held 25,326 shares of Prime Medicine worth $130K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 24,899 Prime Medicine shares in Q2 2024, an estimated $151K.
  • Prime Medicine made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1037 holding.
  • Benjamin F. Edwards & Company first reported a position in Prime Medicine in Q1 2024 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.